Investigating lysosomal membrane proteins using SSM-based electrophysiology: Improving amplification and accessibility

Physiology 2023 (Harrogate, UK) (2023) Proc Physiol Soc 54, PCA037

Poster Communications: Investigating lysosomal membrane proteins using SSM-based electrophysiology: Improving amplification and accessibility

Alison Obergrussberger1, Andre Bazzone1, Maria Barthmes1, Rocco Zerlotti1, Nina Brinkwirth1, Cecilia George1, George Okeyo1, Niels Fertig1,

1Nanion Technologies GmbH Munich Germany, 2Nanion Technologies Inc. Livingston United States,

View other abstracts by:


Introduction

Solid supported membrane-based electrophysiology (SSM-E) offers novel approaches for electrophysiological recordings from lysosomal membrane proteins such as transporters, ligand-gated and leak ion channels in their native membrane environment.

Method

The method of SSM-E relies on the adsorption of any membrane, native, cell culture-derived or organellar, to a lipid coated electrode, i.e the solid supported membrane, and the direct current read-out caused by the capacitive charging of the membranes. The 3 mm diameter electrode entails a >1000-fold amplification of the currents compared with conventional patch clamp, allowing for the measurements of low-conducting membrane proteins, such as transporters. The fact that also intracellular membranes can be accessed by SSM-E, their accessibility for investigation and characterization drastically improves.

Results & Conclusions

Here, we present a study on TMEM175 channels residing in lysosomes using SSM-E. We found an average permeability ratio between protons and potassium of PH/PK = 48.500 and similar conductivities for K+, Rb+, and Cs+. We also found that TMEM175 activity is downregulated to 30% of Imax upon cytosolic acidification with a pK=7.0, while TMEM175 is resistant to lysosomal acidification. We also investigated dose-dependent effects on TMEM175 (n=8 sensors) exerted by blockers, i.e. Zn2+ (IC50 = 1.5 ± 0.2 mM) and 4-AP (IC50 = 1.7 ± 0.3 mM), and enhancers, i.e. DCPIB (EC50 = 10 ± 5 µM; Emax = 275 ± 37 %) and arachidonic acid (EC50 = 2 ± 0.4 µM; Emax = 168 ± 5 %). As expected, the enhancer SC79 which acts via PKA has only little effects on TMEM175 activity (Emax = 109 ± 5 %) in our in vitro assay.

 



Where applicable, experiments conform with Society ethical requirements.

Site search

Filter

Content Type